Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127420841 | 12742084 | 1 | I | 20160829 | 0 | 20160914 | 20160914 | DIR | FDA-CTU | 55.00 | YR | M | N | 0.00000 | 20160913 | N | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127420841 | 12742084 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | D | D | F0026 | 20180731 | 0 | 1 | DF | COATED TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127420841 | 12742084 | 1 | Leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127420841 | 12742084 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127420841 | 12742084 | Anaemia | |
| 127420841 | 12742084 | Ascites | |
| 127420841 | 12742084 | Asthenia | |
| 127420841 | 12742084 | Dehydration | |
| 127420841 | 12742084 | Malnutrition | |
| 127420841 | 12742084 | Renal disorder | |
| 127420841 | 12742084 | Unevaluable event | |
| 127420841 | 12742084 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 127420841 | 12742084 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127420841 | 12742084 | 1 | 20140408 | 201508 | 0 |